FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/26/2025
Back to search
Official data from USPTO
INTELLECTIVE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
INTELLECTIVE
ST13
US500000079376322Class
1, 5, 42
Filing
79376322
Registration
7636660
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
04/03/2026
Trademark type
Word
Nice classes
1, 5, 42
Filing date
06/13/2023
Registration date
01/07/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/07/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CN
Examiner
WOLFE, YOUNG J
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Intellective Biologics (Suzhou) Co., Ltd.
NaTurtle AG
Representatives
Stephanie Goeller Holley & Menker
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancerautoimmune disordersinfectious diseases and cardiovascularpulmonary and neurological conditions; chemicals for use in industry and science; reagents for scientific apparatus for chemical or biological analyses being reagents for scientific and research use; protein in raw material form for scientific and medical research; biochemicals for in-vitro and in-vivo scientific use; biological preparations for use in industry and science; chemical preparations for use in industry; catalysts for chemical processes; diagnostic preparations for scientific use; diagnostic reagents for science or research use; stem cells for research purposes
Class 5
Pharmaceutical products for treating cancerautoimmune disordersinfectious diseases and cardiovascularpulmonary and neurological conditions; medical preparations for the treatment of cancerautoimmune disordersinfectious diseases and cardiovascularpulmonary and neurological conditions; veterinary preparations for vaccinating livestock; disinfectants; preparations for destroying vermin; fungicides; herbicides; dietetic food and beverages adapted for medical use; dietetic pet foods and beverages for veterinary use; food for babies; food supplements; medical plastersmedical dressings; medicines for treating cancerautoimmune disordersinfectious diseases and cardiovascularpulmonary and neurological conditions
Class 42
Research and development of new pharmaceutical productssuch as antibodiesantibody-drug conjugatesfusion proteins and other recombinant proteins; providing information with respect to medical and scientific research in the field of pharmaceutical products; pharmaceutical research and development services; consultation with respect to pharmaceutical research; medical research; scientific research services for medical purposes in the field of pharmaceuticals; biomedical research services; scientific and medical research and developmentresearch and development in the field of medical preparations; design and development of testing and analysis methods for new pharmaceutical product development; scientific research in the nature of conducting clinical trials for others; analysis and evaluation of newly developed pharmaceutical productssuch as antibodiesantibody-drug conjugatesfusion proteins and other recombinant proteins; analysis and evaluation of newly designed pharmaceutical productssuch as antibodiesantibody-drug conjugatesfusion proteins and other recombinant proteins; stem cell research services; scientific research services for medical purposes in the field of proteinsantibodiesmicroorganisms and cells; product research; providing medical and scientific research information in the field of pharmaceutical products and clinical trials; providing information on the results of clinical research trials for pharmaceutical products; consultation with respect to pharmaceutical research and development; providing integrated development of pharmaceutical productsresearch and development of pharmaceutical productsscientific research in the nature of conducting clinical trials and studies for others
Publications
History of USPTO decisions and trademark events.
30 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/03/2025
FIMP
FINAL DISPOSITION PROCESSED
07/03/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/07/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/25/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/08/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/08/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/07/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
01/07/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/19/2024
PUBO
PUBLISHED FOR OPPOSITION
11/19/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/13/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/16/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/16/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/16/2024
RFNT
REFUSAL PROCESSED BY IB
04/23/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/04/2024
RFRR
REFUSAL PROCESSED BY MPU
04/04/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/03/2024
CNRT
NON-FINAL ACTION WRITTEN
04/02/2024
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
03/27/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/05/2024
CNRT
NON-FINAL ACTION WRITTEN
03/04/2024
DOCK
ASSIGNED TO EXAMINER
03/04/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/10/2023
CHLD
CHANGE OF OWNER RECEIVED FROM IB
10/27/2023
MAFR
APPLICATION FILING RECEIPT MAILED
08/15/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/11/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/10/2023
Continuous trademark protection
Get notified about every new filing that threatens INTELLECTIVE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.